SystImmune is a leading and well-funded clinical-stage biopharmaceutical company developing innovative cancer treatments.
SystImmune is a leading clinical-stage biopharmaceutical company developing innovative cancer treatments. The Director/Sr. Director/Executive Director of Clinical Regulatory Affairs will drive regulatory strategy and execution within project development teams and the RA Department. The role will focus on global regulatory aspects of preclinical and clinical areas of Oncology drug development.
SystImmune is a leading and well-funded clinical-stage biopharmaceutical company developing innovative cancer treatments.
Revolution Medicines